Trials / Conditions / Neuroendocrine Tumours (NET)
Neuroendocrine Tumours (NET)
3 registered clinical trials studyying Neuroendocrine Tumours (NET) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for NCT06607692 | Fundación de investigación HM | Phase 1 / Phase 2 |
| Completed | United Kingdom (UK) Patient Preference Study of Somatuline Autogel and Treatment Administration Setting NCT04649580 | Ipsen | — |
| Unknown | A Clinical Study to Assess the Combination of Two Drugs (177Lu-DOTATATE and Nivolumab) in Neuroendocrine Tumou NCT04525638 | Fundación de investigación HM | Phase 2 |